logo

For the Inventor, By the Inventor

Peabody, MA, United States of America

Gregory Patton

This inventor holds 8 USPTO granted patents and 3 published patent applications. Top assignee: New England Biolabs, Inc.. Active years: 2019-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gregory Patton. Retrieved from https://idiyas.com/inventor/gregory-patton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 17(Granted Patents)


Company Filing History:

goldMedal8 out of 345 
 
New England Biolabs, Inc.
 patents

Years Active: 2019-2023

Loading Chart...
8 patents (USPTO):Explore Patents
1. 11732315 - Rapid diagnostic test for lamp (2023-08-22),
2. 11525166 - Rapid diagnostic test for LAMP (2022-12-13),
3. 11492673 - Rapid diagnostic test using colorimetric lamp (2022-11-08),
4. 11345970 - Rapid diagnostic test for LAMP (2022-05-31),
5. 11155887 - Rapid diagnostic test using colorimetric LAMP (2021-10-26),
6. 11008629 - Rapid diagnostic test using colorimetric LAMP (2021-05-18),
7. 10968493 - Rapid diagnostic test using colorimetric LAMP (2021-04-06),
8. 10487317 - Stabilizing 5'-flap endonuclease activity (2019-11-26),

Title: Gregory Patton: Innovator in Rapid Diagnostic Testing

Introduction

Gregory Patton is a notable inventor based in Peabody, MA (US), recognized for his contributions to the field of rapid diagnostic testing. With a total of 8 patents to his name, he has made significant advancements in the detection of target nucleic acids from biological samples. His work focuses on developing methods that are both efficient and user-friendly.

Latest Patents

Among his latest patents, Gregory has developed a rapid diagnostic test for Loop-Mediated Isothermal Amplification (LAMP). This invention includes compositions and methods that allow for specific and sensitive detection of target nucleic acids. The tests are designed to be easy to use, requiring minimal steps while providing rapid and consistent results. These methods utilize labelled probes and are capable of detecting target DNA from various sources, including environmental samples and individual biological specimens. Additionally, his patents address the detection of specific variants of target DNA, including those related to SARS-CoV-2, ensuring high sensitivity and reliability.

Career Highlights

Gregory Patton is currently employed at New England Biolabs, Inc., where he continues to innovate in the field of molecular diagnostics. His work has been instrumental in advancing the capabilities of diagnostic tests, particularly in high-throughput situations. His contributions have not only enhanced the speed of testing but also improved the accuracy of results.

Collaborations

Gregory collaborates with talented individuals such as Nicole Nichols and Nathan Tanner, who contribute to the innovative environment at New England Biolabs, Inc. Their teamwork fosters the development of cutting-edge technologies in the field of diagnostics.

Conclusion

Gregory Patton's work in rapid diagnostic testing exemplifies the impact of innovation in healthcare. His patents and ongoing research continue to pave the way for more effective and efficient diagnostic methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…